CancerVAX, with a valuation of $61.02 million, is raising funds on StartEngine through Reg A+ crowdfunding. It is a pre-clinical biotech company developing a vaccine against cancer. The cancer vaccine of CancerVAX will use the immune system of the body to fight cancer and will have milder side effects than the existing treatments like chemotherapy. The state-of-the-art treatment of CancerVAX is called cancer immunotherapy and will detect, mark, and kill only cancer cells. Ryan Davies founded CancerVAX in 2021. The current crowdfunding campaign has a maximum target of $10 million. The campaign proceeds will be used for research and development and business operations.